US3795772082 - Common Stock
GLOBUS MEDICAL INC - A
NYSE:GMED (12/20/2024, 8:15:03 PM)
After market: 83.85 +1.22 (+1.48%)82.63
+0.69 (+0.84%)
Globus Medical, Inc. operates as a medical device company that develops and commercializes healthcare solutions. The company is headquartered in Audubon, Pennsylvania and currently employs 5,000 full-time employees. The company went IPO on 2012-03-08. The firm offers a portfolio of differentiated technologies that are used to treat a variety of musculoskeletal conditions. Musculoskeletal Solutions consist primarily of implantable devices, biologics, accessories, and surgical instruments used in a range of spinal, orthopedic and neurosurgical procedures. Its spine products address the majority of conditions affecting the spine, including degenerative conditions, deformity, tumors, and trauma. The company provides solutions that facilitate both open and minimally invasive surgery (MIS) techniques. The company includes traditional fusion implants, such as pedicle screws and rod systems. Its orthopedic trauma solutions are designed to treat a variety of orthopedic fracture patterns and patient anatomies in the upper and lower extremities, as well as the hip.
GLOBUS MEDICAL INC - A
2560 General Armistead Ave
Audubon PENNSYLVANIA 19403
P: 16109301800
CEO: David M. Demski
Employees: 5000
Website: https://www.globusmedical.com/
On Wednesday, Inari Medical stock received an upgrade to its Relative Strength (RS) Rating, from 65 to 72.
Unlocking the high Growth Potential of GLOBUS MEDICAL INC - A (NYSE:GMED).
On Tuesday, Novocure stock got a positive adjustment to its Relative Strength (RS) Rating to 96, up from 73.
AUDUBON, Pa., Nov. 22, 2024 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced the...
Here you can normally see the latest stock twits on GMED, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits: